Tibol Tablets 2.5Mg (1 Box = 1 Strip)(1 Strip = 28 Tablets)

Name: Tibol Tablets 2.5Mg (1 Box = 1 Strip)(1 Strip = 28 Tablets)
Brand: ASPIN PHARMA
Price: 1097.32

Brand : aspin pharma

Rs. 1,097.32

Rs. 1,155.00

|

QUICK DELIVERY

Tibol Tablets Specification

Requires Prescription (YES/NO)

Yes

Generics

Tibolone

Used For

Hormone Replacement Therapy

How it works

Tibolone works by mimicking the activity of the female sex hormones, oestrogen and progesterone. It also has some male hormone (androgen) effects. Tibolone helps to restore the balance of female hormones in women who have a lack of oestrogen; it helps to ease symptoms such as hot flushes and night sweats.

Tibol Tablets Usage And Safety

Dosage

Tibolone

Side Effects

Oedema , Lower abdominal pain , Abnormal hair growth , Acne , Pruritus , Vaginal discharge , Endometrial wall thickening , Postmenopausal haemorrhage , Breast tenderness , Genital pruritus , Vaginal candidiasis ,Vaginal haemorrhage , Pelvic pain , Cervical dysplasia , Genital discharge , Vulvovaginitis.

Drug Interactions

Warfarin , cytochrome P450 3A4 inducing compounds barbiturates, carbamazepine, hydantoins and rifampicin .

Indication

It is used for hormonal replacement in post-menopausal women.

When not to Use

• Pregnancy and lactation • Known, past or suspected breast cancer known or suspected estrogen dependent malignant tumors (e.g. endometrial cancer) • Undiagnosed genital bleeding • Untreated endometrial hyperplasia• Previous or current venous thromboembolism (deep venous thrombosis, pulmonary embolism) • Known thrombophilic disorders (e.g. protein C, protein S, or antithrombin deficiency).

Tibol Tablets Precautions

Precaution

The risks of stroke, breast cancer and, in women with an intact uterus, endometrial cancer for each woman should be carefully assessed.

Tibol Tablets Warnings

Warning 1

During treatment, periodic check-ups are recommended of a frequency and nature adapted to the individual woman.

Warning 2

Ovarian cancer is much rarer than breast cancer. Long-term (at least 5-10 years) use of estrogen-only HRT products may be associated with a slightly increased risk of ovarian cancer.

Warning 3

Women should be advised what changes in their breasts should be reported to their doctor or nurse.